Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer

Oncogene
S KulkarniRaymond Tubbs

Abstract

Resistance to anti-HER2 (human epithelial growth factor receptor 2) trastuzumab therapy occurs commonly in HER2-positive breast cancer and involves overactivation of HER2 and/or AKT1. Using the model of trastuzumab-sensitive or trastuzumab-resistant HER2-positive cells with wild-type PTEN, negative regulator of AKT1, we explore the involvement of cysteine protease calpain in mechanisms of trastuzumab resistance. Overexpression of calpain1 or activation of endogenous calpain during adhesion or trastuzumab treatment of trastuzumab-sensitive cells induces cleavage of cytoplasmic domains of HER2/phospho-HER2; cleavage occurs in HER2-positive tumors. Expression of the catalytically inactive mutant of calpain1 reduces the cleavage to enhance the activity of HER2, inactivates PTEN to enhance the activation of AKT1, induces desensitization to trastuzumab and promotes survival of trastuzumab-sensitive cells. In the model of trastuzumab resistance, constitutive overactivation of HER2 and AKT1 correlates with reduced activation of calpain. Moreover, inhibitors of the catalytic site of calpain reduce the increase in constitutive activity of AKT1 and survival of trastuzumab-resistant cells selectively. Together, by regulating the activation...Continue Reading

References

Jul 15, 1994·European Journal of Biochemistry·M GregoriouC Crawford
Jul 20, 1999·The Journal of Biological Chemistry·S KulkarniJ E Fox
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelMichael Press
Jul 5, 2003·Physiological Reviews·Darrell E GollJinyang Cong
Nov 8, 2003·Cancer Chemotherapy and Pharmacology·Rita Nahta, Francisco J Esteva
Feb 6, 2004·Breast Cancer Research and Treatment·Marc Lacroix, Guy Leclercq
May 4, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hongbo ZhuBingliang Fang
Oct 21, 2005·The New England Journal of Medicine·Martine J Piccart-GebhartUNKNOWN Herceptin Adjuvant (HERA) Trial Study Team
Nov 11, 2005·Molecular Biology of the Cell·Benjamin J PerrinAnna Huttenlocher
Dec 13, 2005·Nature Reviews. Drug Discovery·Bryan T HennessyGordon B Mills
Apr 25, 2006·The Journal of Biological Chemistry·Yinfei TanPeter A Greer
May 6, 2006·Gene·Arne GerickeAlonzo H Ross
Aug 4, 2006·Cancer Research·Izabela Młynarczuk-BiałyUlrike Seifert
Dec 19, 2006·Oncogene·R C IshizawarS J Parsons
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christoph A RitterCarlos L Arteaga
Nov 13, 2007·Advances in Experimental Medicine and Biology·Mary M Zutter
Aug 5, 2008·Cancer Research·Katherine Stemke-HaleBryan T Hennessy

❮ Previous
Next ❯

Citations

Sep 25, 2012·Journal of the American Chemical Society·Hyunil JoDoron C Greenbaum
Mar 20, 2012·The Journal of Biological Chemistry·Wai-chi HoPeter A Greer
Jul 11, 2013·Journal of Oncology·Minfei SuSangita Sinha
Apr 22, 2011·Nature Reviews. Cancer·Sarah J StorrStewart G Martin
Jan 20, 2011·Expert Opinion on Therapeutic Targets·Ludovic Leloup, Alan Wells
Jan 30, 2014·Journal of the American Chemical Society·Jacob M GoldbergE James Petersson
Mar 2, 2012·International Journal of Cancer. Journal International Du Cancer·Sucheta KulkarniRaymond Tubbs
Dec 9, 2010·International Journal of Cancer. Journal International Du Cancer·Sarah J StorrStewart G Martin
Aug 11, 2015·Pharmacogenomics·Adela Madrid-ParedesMiguel Ángel Calleja-Hernández
Oct 12, 2014·Archives of Biochemistry and Biophysics·Daniele MorettiEmilia Maellaro
Nov 12, 2016·Nature Reviews. Drug Discovery·Yasuko OnoHiroyuki Sorimachi
May 24, 2018·FEBS Letters·Matthew KreitmanYosef Yarden
May 25, 2016·Molecular and Cellular Biology·Stacy GrievePeter A Greer
Oct 27, 2010·Annals of the New York Academy of Sciences·Jason A Wilken, Nita J Maihle
Feb 9, 2017·Genes, Chromosomes & Cancer·Sucheta KulkarniUmamaheswar Duvvuri
Jul 13, 2016·The Biochemical Journal·Lucía Rodríguez-FernándezElena R García-Trevijano
May 23, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sreya DasRahul Purwar
May 3, 2011·The Breast : Official Journal of the European Society of Mastology·Sarah J StorrStewart G Martin

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.